PHARMAZEUTISCHE ZUSAMMENSETZUNG ENTHALTEND EINEN EMBRYONALEN EXTRAKT UND VERFAHREN ZU IHRER HERSTELLUNG

摘要

Pharmaceutical composition suitable for the treatment of the tumours and the other pathologies controlled by the p53 antioncogene, containing an embryonic or gravid uterus extract as an active substance, wherein said extract comes from embryos or uteri taken at a specific stage of the embryonic development, chosen related to the specific pathology and dependent upon the species of origin of the embryos and uteri, and a process for the preparation thereof.